Skip to main content
. 2021 Jun 3;13(11):2791. doi: 10.3390/cancers13112791

Figure 6.

Figure 6

Clinico-genomic model. A clinico-genomic model considering clinical parameters and genomic alterations was developed to predict patient survival. (A) Selected factors to establish the clinico-genomic model. (B) Kaplan–Meier plot for the high-risk group and the low-risk group of patients with pancreatic ductal adenocarcinoma (PDAC) predicted by the clinico-genomic model (p < 0.0001).